Characteristics associated with treatment response and satisfaction in women undergoing onabotulinumtoxinA and sacral neuromodulation for refractory urgency urinary incontinence

Richter, H. E., Amundsen, C. L., Erickson, S. W., Jelovsek, J. E., Komesu, Y., Chermansky, C., Harvie, H. S., Albo, M., Myers, D., Gregory, W. T., Wallace, D., & NICHD Pelvic Floor Disorders Netwo (2017). Characteristics associated with treatment response and satisfaction in women undergoing onabotulinumtoxinA and sacral neuromodulation for refractory urgency urinary incontinence. Obstetrical & Gynecological Survey, 72(12), 709-711. https://doi.org/10.1097/01.ogx.0000527551.60666.74

Abstract

Primary treatment approaches for women with urgency urinary incontinence (UUI) include medications and behavioral therapy. Patients with UUI refractory to primary treatments may be offered third-line treatment options such as sacral neuromodulation (SNM) or onabotulinumtoxinA.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

The daily association between affect and alcohol use: A meta-analysis of individual participant data
Article

Protection of forest ecosystems in the eastern United States from elevated atmospheric deposition of sulfur and nitrogen
Article

The use of patient experience feedback in rehabilitation quality improvement and codesign activities
Article

SPTSSA variants alter sphingolipid synthesis and cause a complex hereditary spastic paraplegia